VR Pilot for Pancreatitis

Inclusion Criteria: * Diagnosis of CP \[as determined by Cambridge 3-4 imaging classification (using CT, MRI, or MRCP) or a histologic diagnosis of CP\] * Clinically significant abdominal pain, measured using the standardized NIH PROMIS GI Pain Scale14 and defined as scoring at least 5 points above the nationally normed score (0.5 SD effect size), indicating equal or greater than the minimally clinically important difference (MCID) of abdominal pain * Are 18-75 years of age * Are able to read/write English. The study does not include non-English speakers as to current study material are only available in English. Exclusion Criteria: * Patients who are presenting with a condition that interferes with VR usage (e.g., seizures, facial injury precluding safe placement of headset, visual impairment) * Patients who have cognitive impairment that affects protocol participation * Patients who are recommended for long-term hospitalization * Patients who are estimated to live \<3 months from the time of enrollment * Patients who have been diagnosed with a pancreatic tumor * Patients who have been enrolled in an interventional/therapeutic drug trial for chronic or recurrent pancreatitis within the last 6 months